Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Charlotte's Web Holdings (CWBHF)
OTHER OTC:CWBHF
RESEARCH TOOLSreports
Charlotte's Web Holdings (CWBHF) Stock Price & Analysis
1,010 Followers
CWBHF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.17 - $0.73
Previous Close$0.2
Volume138.77K
Average Volume (3M)177.89K
Market Cap
$30.17M
Enterprise Value$27.52M
Total Cash (Recent Filing)$61.73M
Total Debt (Recent Filing)$59.08M
Price to Earnings (P/E)-0.6
Beta1.36
Next Earnings
Mar 21, 2024EPS Estimate
-$0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding153,788,799
10 Day Avg. Volume168,574
30 Day Avg. Volume177,893
Standard Deviation0.30
R-Squared0.13
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.76
Price to Sales (P/S)1.92
Price to Cash Flow (P/CF)9.60
P/FCF Ratio11.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.53
Enterprise Value/Gross Profit1.42
Enterprise Value/Ebitda3.57
Forecast
1Y Price Target
$0.67Price Target Upside228.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Charlotte's Web Holdings News
Pre-EarningsCWBHF Upcoming Earnings Report: What to Expect?
Pre-EarningsCWBHF Upcoming Earnings Report: What to Expect?
Ownership Overview
12.05% Insiders
0.00% Mutual Funds
5.20% Other Institutional Investors
82.75% Public Companies and
Individual Investors
CWBHF FAQ
What was Charlotte's Web Holdings’s price range in the past 12 months?
Charlotte's Web Holdings lowest stock price was $0.17 and its highest was $0.73 in the past 12 months.
What is Charlotte's Web Holdings’s market cap?
Currently, no data Available
When is Charlotte's Web Holdings’s upcoming earnings report date?
Charlotte's Web Holdings’s upcoming earnings report date is Mar 21, 2024 which is in 107 days.
How were Charlotte's Web Holdings’s earnings last quarter?
Charlotte's Web Holdings released its earnings results on Nov 09, 2023. The company reported -$0.1 earnings per share for the quarter, missing the consensus estimate of -$0.05 by -$0.05.
Is Charlotte's Web Holdings overvalued?
According to Wall Street analysts Charlotte's Web Holdings’s price is currently Undervalued.
Does Charlotte's Web Holdings pay dividends?
Charlotte's Web Holdings does not currently pay dividends.
What is Charlotte's Web Holdings’s EPS estimate?
Charlotte's Web Holdings’s EPS estimate is -$0.07.
How many shares outstanding does Charlotte's Web Holdings have?
Charlotte's Web Holdings has 153,788,800 shares outstanding.
What happened to Charlotte's Web Holdings’s price movement after its last earnings report?
Charlotte's Web Holdings reported an EPS of -$0.1 in its last earnings report, missing expectations of -$0.05. Following the earnings report the stock price went down -3.846%.
Which hedge fund is a major shareholder of Charlotte's Web Holdings?
Currently, no hedge funds are holding shares in CWBHF
---
Charlotte's Web Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$0.67 (228.11% Upside)
$0.67 (228.11% Upside)
Blogger Sentiment
Neutral
CWBHF Sentiment 50%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $80.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 1.4%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-68.30%
12-Months-Change
Fundamentals
Return on Equity
-58.45%
Trailing 12-Months
Asset Growth
16.62%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Charlotte's Web Holdings
Charlotte's Web Holdings, Inc. engages in the production and distribution of hemp-based, cannabinoid wellness products. Its products is comprised of tinctures, capsules, topical products, powdered supplements, single-use, beverage, and sport and professional products. The company was founded by Joel Stanley and Jared Stanley in 2013 and is headquartered in Boulder, CO.
---
OrganiGram Holdings
―
Village Farms International
―
Trevi Therapeutics
―
Lyra Therapeutics
―
---